Cargando…
Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?
We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitud...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267933/ https://www.ncbi.nlm.nih.gov/pubmed/31789477 http://dx.doi.org/10.1002/hbm.24884 |
_version_ | 1783541507766091776 |
---|---|
author | Gorges, Martin Kunz, Martin S. Müller, Hans‐Peter Liepelt‐Scarfone, Inga Storch, Alexander Dodel, Richard Hilker‐Roggendorf, Rüdiger Berg, Daniela Kalbe, Elke Braak, Heiko Del Tredici, Kelly Baudrexel, Simon Huppertz, Hans‐Jürgen Kassubek, Jan |
author_facet | Gorges, Martin Kunz, Martin S. Müller, Hans‐Peter Liepelt‐Scarfone, Inga Storch, Alexander Dodel, Richard Hilker‐Roggendorf, Rüdiger Berg, Daniela Kalbe, Elke Braak, Heiko Del Tredici, Kelly Baudrexel, Simon Huppertz, Hans‐Jürgen Kassubek, Jan |
author_sort | Gorges, Martin |
collection | PubMed |
description | We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitudinal 3T MRI data (up to four follow‐up assessments) from neuropsychologically well‐characterized advanced PD patients (n = 172, 8.9 years disease duration) and healthy elderly controls (n = 85) enrolled in the LANDSCAPE study were longitudinally analyzed using a linear mixed effect model and atlas‐based volumetry and cortical thickness measures. At baseline, PD patients presented with cerebral atrophy and cortical thinning including striatum, temporoparietal regions, and primary/premotor cortex. The atrophy was already observed in “cognitively normal” PD patients (PD‐N) and was considerably more pronounced in cognitively impaired PD patients. Linear mixed effect modeling revealed almost similar rates of atrophy change in PD and controls. The group comparison at baseline between those PD‐N whose cognitive performance remained stable (n = 42) and those PD‐N patients who converted to MCI/PDD (“converter” cPD‐N, n = 26) indicated suggested cortical thinning in the anterior cingulate cortex in cPD‐N patients which was correlated with cognitive performance. Our results suggest that cortical brain atrophy has been already expanded in advanced PD patients without overt cognitive deficits while atrophy progression in late disease did not differ from “normal” aging regardless of the cognitive status. It appears that cortical atrophy begins early and progresses already in the initial disease stages emphasizing the need for therapeutic interventions already at disease onset. |
format | Online Article Text |
id | pubmed-7267933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72679332020-06-12 Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? Gorges, Martin Kunz, Martin S. Müller, Hans‐Peter Liepelt‐Scarfone, Inga Storch, Alexander Dodel, Richard Hilker‐Roggendorf, Rüdiger Berg, Daniela Kalbe, Elke Braak, Heiko Del Tredici, Kelly Baudrexel, Simon Huppertz, Hans‐Jürgen Kassubek, Jan Hum Brain Mapp Research Articles We investigated the brain atrophy distribution pattern and rate of regional atrophy change in Parkinson's disease (PD) in association with the cognitive status to identify the morphological characteristics of conversion to mild cognitive impairment (MCI) and dementia (PDD). T1‐weighted longitudinal 3T MRI data (up to four follow‐up assessments) from neuropsychologically well‐characterized advanced PD patients (n = 172, 8.9 years disease duration) and healthy elderly controls (n = 85) enrolled in the LANDSCAPE study were longitudinally analyzed using a linear mixed effect model and atlas‐based volumetry and cortical thickness measures. At baseline, PD patients presented with cerebral atrophy and cortical thinning including striatum, temporoparietal regions, and primary/premotor cortex. The atrophy was already observed in “cognitively normal” PD patients (PD‐N) and was considerably more pronounced in cognitively impaired PD patients. Linear mixed effect modeling revealed almost similar rates of atrophy change in PD and controls. The group comparison at baseline between those PD‐N whose cognitive performance remained stable (n = 42) and those PD‐N patients who converted to MCI/PDD (“converter” cPD‐N, n = 26) indicated suggested cortical thinning in the anterior cingulate cortex in cPD‐N patients which was correlated with cognitive performance. Our results suggest that cortical brain atrophy has been already expanded in advanced PD patients without overt cognitive deficits while atrophy progression in late disease did not differ from “normal” aging regardless of the cognitive status. It appears that cortical atrophy begins early and progresses already in the initial disease stages emphasizing the need for therapeutic interventions already at disease onset. John Wiley & Sons, Inc. 2019-12-02 /pmc/articles/PMC7267933/ /pubmed/31789477 http://dx.doi.org/10.1002/hbm.24884 Text en © 2019 The Authors. Human Brain Mapping published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Gorges, Martin Kunz, Martin S. Müller, Hans‐Peter Liepelt‐Scarfone, Inga Storch, Alexander Dodel, Richard Hilker‐Roggendorf, Rüdiger Berg, Daniela Kalbe, Elke Braak, Heiko Del Tredici, Kelly Baudrexel, Simon Huppertz, Hans‐Jürgen Kassubek, Jan Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title_full | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title_fullStr | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title_full_unstemmed | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title_short | Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters? |
title_sort | longitudinal brain atrophy distribution in advanced parkinson's disease: what makes the difference in “cognitive status” converters? |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267933/ https://www.ncbi.nlm.nih.gov/pubmed/31789477 http://dx.doi.org/10.1002/hbm.24884 |
work_keys_str_mv | AT gorgesmartin longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT kunzmartins longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT mullerhanspeter longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT liepeltscarfoneinga longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT storchalexander longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT dodelrichard longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT hilkerroggendorfrudiger longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT bergdaniela longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT kalbeelke longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT braakheiko longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT deltredicikelly longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT baudrexelsimon longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT huppertzhansjurgen longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters AT kassubekjan longitudinalbrainatrophydistributioninadvancedparkinsonsdiseasewhatmakesthedifferenceincognitivestatusconverters |